A-TANGO Masterclass: Reimbursement in Healthcare (Louise Perrault, IMAC)

Effective treatment of acute-on-chronic liver failure (#ACLF) is an urgent and unmet need. The A-TANGO consortium tests and evaluates an innovative new treatment that aims to reduce inflammation and improve hepatocyte proliferation by repurposing TAK-242, an antagonist of toll-like receptor 4, in combination with G-CSF (granulocyte colony-stimulating factor). We call this novel combinatorial therapy G-TAK. In addition, A-TANGO strives to identify reliable biomarkers for better patient stratification and an increased survival rate.
In this Masterclass, Louise Perrault, Founder and CEO of International Market Access Consulting (IMAC) and A-TANGO consortium member, gives an in-depth Masterclass lecture on the importance of a solid #MarketAccess strategy for any novel #therapy, healthcare product, or medical service, how to access the #HealthcareMarket, and how to receive #reimbursement in #healthcare The public Masterclass was held virtually on 27th March 2024 and recorded as part of the project's early-career scientists (ECS) training programme.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945096. This video reflects only the presenter's view and the European Commission is not responsible for any use that may be made of the information it contains.
Recording, production, and subtitles: Dr. Nina Donner, Tassilo Steinmann, Regina Puga
concentris.de © 2024 A-TANGO